Lab On-Chip And Microarrays Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Lab On-Chip and Microarrays Market : By Product Type (Lab-On-A-Chips (PDMS Lab-On-A-Chip, Thermo Polymers Lab-On-A-Chip, Glass LAB-ON-A-CHIP, Silicon Lab-On-A-Chip, Paper Lab-On-A-Chip) Microarrays (DNA Microarrays, Tissue Microarrays, Protein Microarray, Others)), By End User (Biotechnology and Pharmaceutical Firms, Academic and Research Institutions, Hospitals and Diagnostic Centres) and Geography 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global lab on-chip and microarrays market size expected to reach USD 10.2 billion by 2027, at a CAGR of 9.4% during forecast period 2021 to 2027. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a chip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share. For instance, in November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products. For instance, in March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.

Lab On-Chip And Microarrays Market

MARKET SUMMARY
-
9.4% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 9.4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Lab On-Chip And Microarrays Market

  • The report on global lab on chip and microarrays market gives historical, current and future market sizes (US$ Bn) based on product type, end-user and region.
  • lab on chip and microarrays market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Affymetrix Inc. (U.S.),
  • Abbott Laboratories (U.S.),
  • Agilent Technologies (U.S.),
  • Biomerieux SA (France),
  • Beckman Coulter Inc. (U.S.), and
  • CombiMatrix Molecular Diagnostics
Lab On-Chip And Microarrays Market

Drivers And Restraints

Global lab on chip and microarrays market is mainly driven by the increase in the adaptation of lab on chip and microarrays in various research fields such as drug discovery, genomics, proteomics and others. In addition, increase in demand for personalized medicine and increase in prevalence rates of cancer that led to the demand for the development of R&D related to cancer diagnostics and treatment expected to boost the global lab on chip and microarrays market over the forecast period. However, a high cost of devices and stringent regulations for research on genomes are expected to hamper the market growth over the forecast period.


North-America got significant share

Lab On-Chip And Microarrays Market

Geographically global Lab On-Chip and Microarrays is segmented as Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America expected to contribute major growth in global lab-on-chip and microarrays market owing to increase in research and development activities related to cancer and gene sequencing technologies and increase in an adaptation of microarray and lab-on-chip products for diagnosis. Europe is expected to be another major market owing to rising cancer prevalence that leading to the need for the development of reliable and fast diagnostics. Asia Pacific is expected to grow at significant rates owing to the low cost of raw materials and developing healthcare infrastructure.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

In October 2015, Affymetrix launched new genotype array, The Axiom Transplant Genotype Array, a first array focused on transplant genomics, to help scientists uncover the mechanics of transplant rejection.


Key

Key Features of the Report

Lab On-Chip And Microarrays Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Affymetrix Inc. (U.S.)
  • Abbott Laboratories (U.S.)
  • Agilent Technologies (U.S.)
  • Biomerieux SA (France)
  • Beckman Coulter Inc. (U.S.)
  • CombiMatrix Molecular Diagnostics (CombiMatrix Corp.) (U.S.)

Description

The global lab on-chip and microarrays market size expected to reach USD 10.2 billion by 2027, at a CAGR of 9.4% during forecast period 2021 to 2027. Lab on the chip an evolutionary device which integrates single or many laboratory functions on one integrated circuit commonly, a chip. Lab-on-chip generally measures about few square centimetres and used to achieve automation and high through screening. The microarray is the most recent advances in the cancer research. Microarrays help to analyse plenty of samples which have already been recorded or new samples, it even helps to test the incidence of a particular marker in tutors. There are two types of microarrays, gene expression microarrays and tissue microarrays. The lab on-chip and microarrays market has very few and dominant players who are actively participating in research and development of the new products. Companies are launching the new products to increase the market share. For instance, in November 2016, Abbott laboratories received CE mark for its innovative blood testing device i-STAT Alinity point of care system, a portable device that can perform and analyse largest menu of blood tests on a single device. Furthermore, companies are collaborating in the development of the new products. For instance, in March 2016, CombiMatrix Molecular Diagnostics (CMDX) and Array Genomics Inc. entered into the collaboration agreement to develop and market a series of comparative genomic hybridization (CGH) microarray products.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX